Patents by Inventor Shuang CAO

Shuang CAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250012846
    Abstract: A method for testing the total dose effect of a SiC MOSFET device, realizing verification of the complex total dose effect of the SiC MOSFET. The test steps sequentially comprise: testing a tested device before irradiation; performing annealing treatment on the tested device before irradiation; performing an irradiation test on the tested device; performing annealing treatment on the tested device after irradiation; performing test data analysis and processing on the tested device after irradiation. In the test process, threshold voltage shift caused by total dose radiation-induced defects and threshold voltage shift caused by near interface trap charges inherent near a SiC MOSFET interface are measured respectively, comprehensive analysis and calculation are carried out on the test result, the total dose effect resistance capability of the SiC MOSFET device can be given, and a certain guiding effect on device reinforcement is achieved.
    Type: Application
    Filed: November 4, 2022
    Publication date: January 9, 2025
    Applicant: CHINA ACADEMY OF SPACE TECHNOLOGY
    Inventors: Qingkui YU, He WANG, Shuang CAO, Yi SUN, Bo MEI, He LV, Rigen MO, Qianyuan WANG, Jiajia SUN, Hongwei ZHANG
  • Patent number: 12127856
    Abstract: The present disclosure relates to a difficult airway evaluation method and device based on a machine learning voice technology. The method includes the following steps: acquiring voice data of a patient; carrying out feature extraction on the voice data, obtaining a pitch period of pronunciations, and acquiring a voiced sound feature and unvoiced sound features based on the pitch period of pronunciations; and constructing a difficult airway evaluation classifier based on the machine learning voice technology, analyzing the received voiced sound feature and unvoiced sound features by the trained difficult airway evaluation classifier, and carrying out scoring on the severity of a difficult airway to obtain an evaluation result of the difficult airway.
    Type: Grant
    Filed: July 7, 2022
    Date of Patent: October 29, 2024
    Assignee: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
    Inventors: Hong Jiang, Ming Xia, Ren Zhou, Shuang Cao, Tian Yi Xu, Jie Wang, Chen Yu Jin, Bei Pei
  • Publication number: 20240037219
    Abstract: Trusted execution environment construction is described and includes obtaining regulatory requirement information of a trusted execution environment. The regulatory requirement information is parsed to obtain atomized security function information applied to the trusted execution environment. Formal parsing processing is performed on the security function information to obtain a security solution of the trusted execution environment to prove that it satisfies the regulatory requirement information and generating a test case corresponding to the security solution based on an axiom of the security solution. Using a predetermined property migration mechanism based on the security solution and the test case corresponding to the security solution, a trusted execution environment is constructed that has same property information as the security solution and the test case with respect to a predetermined property item in a target scenario.
    Type: Application
    Filed: October 6, 2023
    Publication date: February 1, 2024
    Applicant: Alipay (Hangzhou) Information Technology Co., Ltd.
    Inventor: Shuang Cao
  • Publication number: 20230044289
    Abstract: The present disclosure relates to a difficult airway evaluation method and device based on a machine learning voice technology. The method includes the following steps: acquiring voice data of a patient; carrying out feature extraction on the voice data, obtaining a pitch period of pronunciations, and acquiring a voiced sound feature and unvoiced sound features based on the pitch period of pronunciations; and constructing a difficult airway evaluation classifier based on the machine learning voice technology, analyzing the received voiced sound feature and unvoiced sound features by the trained difficult airway evaluation classifier, and carrying out scoring on the severity of a difficult airway to obtain an evaluation result of the difficult airway.
    Type: Application
    Filed: July 7, 2022
    Publication date: February 9, 2023
    Applicant: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
    Inventors: Hong Jiang, Ming Xia, Ren Zhou, Shuang Cao, Tian Yi Xu, Jie Wang, Chen Yu Jin, Bei Pei
  • Publication number: 20220301717
    Abstract: The disclosure relates to an artificial intelligence-based difficult airway evaluation method and device. The method includes the following steps: acquiring facial images of various postures; constructing a feature extraction network based on facial recognition, and extracting feature information of the facial images through the trained feature extraction network; and constructing a difficult airway classifier based on a machine learning algorithm, and performing difficult airway severity scoring on the extracted feature information of the facial images through the trained difficult airway classifier to obtain an evaluation result of a difficult airway. According to the present disclosure, early warning can be accurately provided for difficult airways in clinical anesthesia.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
    Inventors: Ming Xia, Hong Jiang, Zhi Liang Lin, Yao Kun Zheng, Jie Wang, Ren Zhou, Tian Yi Xu, Shuang Cao
  • Patent number: 11180463
    Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: November 23, 2021
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Wu Zhong, Shuang Cao, Lili Wang, Zhibing Zheng, Junhai Xiao, Xinbo Zhou
  • Patent number: 10989695
    Abstract: Disclosed are an online monitoring system for a crack on a hoist spindle and an operation method thereof. The system comprises: a rope power part, a crack detection part, a wireless transmission part, and a computer. The rope power part comprises two traction ropes, two guide wheels, two stepper motors, and two stepper motor drivers. The crack detection part comprises a spiral tube guide rail, a sliding body, and an ultrasonic generator. The wireless transmission part comprises three zigbee wireless sensing modules. The zigbee wireless sensing modules receive instructions from the computer and transmit the instructions to the stepper motor drivers to control the motors to rotate. The stepper motors drive the guide wheels to rotate to realize the winding of the ropes, so as to pull the sliding body to slide on the spiral tube guide rail. The ultrasonic generator clamped on the sliding body monitors the rotating spindle along the spiral tube guide rail.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 27, 2021
    Assignee: China University of Mining and Technology
    Inventors: Zhencai Zhu, Hao Lu, Shuang Cao, Yuxing Peng, Gongbo Zhou, Guohua Cao, Gang Shen, Wei Li, Dagang Wang, Fan Jiang
  • Publication number: 20210041402
    Abstract: Disclosed are an online monitoring system for a crack on a hoist spindle and an operation method thereof. The system comprises: a rope power part, a crack detection part, a wireless transmission part, and a computer. The rope power part comprises two traction ropes, two guide wheels, two stepper motors, and two stepper motor drivers. The crack detection part comprises a spiral tube guide rail, a sliding body, and an ultrasonic generator. The wireless transmission part comprises three zigbee wireless sensing modules. The zigbee wireless sensing modules receive instructions from the computer and transmit the instructions to the stepper motor drivers to control the motors to rotate. The stepper motors drive the guide wheels to rotate to realize the winding of the ropes, so as to pull the sliding body to slide on the spiral tube guide rail. The ultrasonic generator clamped on the sliding body monitors the rotating spindle along the spiral tube guide rail.
    Type: Application
    Filed: July 11, 2019
    Publication date: February 11, 2021
    Applicant: China University of Mining and Technology
    Inventors: Hao LU, Shuang CAO, Zhencai ZHU, Yuxing PENG, Gongbo ZHOU, Guohua CAO, Gang SHEN, Wei LI, Dagang WANG, Fan JIANG
  • Publication number: 20190233383
    Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 1, 2019
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song LI, Wu ZHONG, Shuang CAO, Lili WANG, Zhibing ZHENG, Junhai XIAO, Xinbo ZHOU
  • Patent number: 10160767
    Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a rapamycin derivative of Formula I, and a preparation method, pharmaceutical composition and use thereof. The compounds of the present invention overcome the defects of rapamycin in terms of water solubility and metabolic properties, and some of the compounds have an in vitro anti-tumor activity superior to rapamycin, have less toxicity to normal cells than rapamycin, and have very good druggability.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: December 25, 2018
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Wu Zhong, Song Li, Shuang Cao, Ruiyuan Cao, Junhai Xiao, Xinbo Zhou, Xingzhou Li
  • Publication number: 20170253606
    Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a rapamycin derivative of Formula I, and a preparation method, pharmaceutical composition and use thereof. The compounds of the present invention overcome the defects of rapamycin in terms of water solubility and metabolic properties, and some of the compounds have an in vitro anti-tumor activity superior to rapamycin, have less toxicity to normal cells than rapamycin, and have very good druggability.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 7, 2017
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Wu ZHONG, Song LI, Shuang CAO, Ruiyuan CAO, Junhai XIAO, Xinbo ZHOU, Xingzhou LI
  • Publication number: 20160137619
    Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.
    Type: Application
    Filed: July 9, 2014
    Publication date: May 19, 2016
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song LI, Wu ZHONG, Shuang CAO, Lili WANG, Zhibing ZHENG, Junhai XIAO, Xinbo ZHOU